Avenue Biosciences is a transatlantic biotech building the first platform to measure and modulate the cellular secretory pathway at scale. Spun out of the University of Helsinki and headquartered between Helsinki and Palo Alto, the company pairs high-throughput chemistry with machine learning to design signal peptides and boost yields of therapeutic proteins - biologics, biosimilars, and mRNA-encoded medicines - so that production bottlenecks stop limiting which therapies reach patients.
Janan Ganesh is the Financial Times' biweekly columnist and associate editor, one of the most widely read political essayists writing in English. Born in Nigeria, raised in South London, he reasons his way to conclusions other commentators won't reach: that Keir Starmer may need to fail, that Trump and MAGA have come apart, that the West misreads its own decline. He spent four years covering America from Washington and Los Angeles before returning to London in 2022, and his Saturday FT Weekend column ranges freely across cities, football, restaurants, art and the texture of the good life.
Kori Schake runs foreign and defense policy studies at the American Enterprise Institute and is one of Washington's most quoted voices on alliances, deterrence, and the future of NATO. A Stanford-trained scholar who studied under Condoleezza Rice, she spent a decade and a half inside the Pentagon, the National Security Council, and the State Department before becoming a leading public intellectual on grand strategy. She is the author of several books on hegemony and civil-military relations, a contributing writer at The Atlantic, and a Republican national security thinker known for breaking with her party over Donald Trump.